Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance.
|
Hepatology
|
1993
|
8.76
|
2
|
The many faces of multivisceral transplantation.
|
Surg Gynecol Obstet
|
1991
|
6.89
|
3
|
Liver, kidney, and thoracic organ transplantation under FK 506.
|
Ann Surg
|
1990
|
5.01
|
4
|
Intestinal transplantation in composite visceral grafts or alone.
|
Ann Surg
|
1992
|
4.96
|
5
|
Murine liver allograft transplantation: tolerance and donor cell chimerism.
|
Hepatology
|
1994
|
4.32
|
6
|
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement.
|
Lancet
|
1990
|
4.18
|
7
|
Liver transplantation in the United States, 1999-2008.
|
Am J Transplant
|
2010
|
3.92
|
8
|
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats.
|
Transplantation
|
1995
|
3.63
|
9
|
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics.
|
Transplant Proc
|
1991
|
3.40
|
10
|
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease.
|
Hepatology
|
1991
|
3.34
|
11
|
Early trials with FK 506 as primary treatment in liver transplantation.
|
Transplant Proc
|
1990
|
3.29
|
12
|
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection.
|
Nephron
|
1987
|
3.26
|
13
|
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts.
|
Surgery
|
1990
|
3.18
|
14
|
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver.
|
Transplantation
|
1991
|
3.14
|
15
|
Long-term survival after liver transplantation in 4,000 consecutive patients at a single center.
|
Ann Surg
|
2000
|
2.91
|
16
|
Functional characterization of infiltrating T lymphocytes in human hepatic allografts.
|
Hum Immunol
|
1986
|
2.84
|
17
|
Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation.
|
Transplant Proc
|
1993
|
2.81
|
18
|
Cadaveric small bowel and small bowel-liver transplantation in humans.
|
Transplantation
|
1992
|
2.75
|
19
|
Management of intestinal transplantation in humans.
|
Transplant Proc
|
1992
|
2.62
|
20
|
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations.
|
Transplant Proc
|
1990
|
2.60
|
21
|
Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy.
|
Transplantation
|
1990
|
2.59
|
22
|
Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506.
|
Transplant Proc
|
1991
|
2.59
|
23
|
The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study.
|
Hepatology
|
1997
|
2.57
|
24
|
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression.
|
Transplantation
|
1994
|
2.50
|
25
|
Pregnancy after liver transplantation under tacrolimus.
|
Transplantation
|
1997
|
2.50
|
26
|
Pharmacokinetics of FK 506: preclinical and clinical studies.
|
Transplant Proc
|
1990
|
2.48
|
27
|
Prioritization and organ distribution for liver transplantation.
|
JAMA
|
1994
|
2.38
|
28
|
The antibody crossmatch in liver transplantation.
|
Surgery
|
1986
|
2.33
|
29
|
The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation.
|
Ann Surg
|
1994
|
2.32
|
30
|
Clinical intestinal transplantation: new perspectives and immunologic considerations.
|
J Am Coll Surg
|
1998
|
2.31
|
31
|
Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression.
|
Transplant Proc
|
1991
|
2.28
|
32
|
Assessment of five-year experience with abdominal organ cluster transplantation.
|
J Am Coll Surg
|
1995
|
2.25
|
33
|
Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level?
|
Am J Transplant
|
2015
|
2.24
|
34
|
Immunosuppression: evolution in practice and trends, 1994-2004.
|
Am J Transplant
|
2006
|
2.22
|
35
|
Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system.
|
J Am Coll Surg
|
1999
|
2.22
|
36
|
Human islet isolation and allotransplantation in 22 consecutive cases.
|
Transplantation
|
1992
|
2.20
|
37
|
Three years clinical experience with intestinal transplantation.
|
J Am Coll Surg
|
1994
|
2.20
|
38
|
Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts.
|
Gastroenterology
|
1999
|
2.19
|
39
|
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases.
|
Liver Transpl Surg
|
1997
|
2.16
|
40
|
Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium.
|
Clin Infect Dis
|
1996
|
2.12
|
41
|
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults.
|
Transplant Proc
|
1991
|
2.10
|
42
|
A prospective randomized trial of FK506-based immunosuppression after renal transplantation.
|
Transplantation
|
1995
|
2.09
|
43
|
The side effects of FK 506 in humans.
|
Transplant Proc
|
1990
|
2.08
|
44
|
Randomised trialomania? The multicentre liver transplant trials of tacrolimus.
|
Lancet
|
1995
|
2.04
|
45
|
Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation.
|
J Am Coll Surg
|
1998
|
1.99
|
46
|
Prevention of graft-versus-host disease following allogeneic bone marrow transplantation in rats using FK506.
|
Transplantation
|
1991
|
1.95
|
47
|
FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood.
|
Lancet
|
1990
|
1.94
|
48
|
Successful hamster-to-rat liver xenotransplantation under FK506 immunosuppression induces unresponsiveness to hamster heart and skin.
|
Transplantation
|
1993
|
1.94
|
49
|
Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria.
|
Liver Transpl
|
2000
|
1.88
|
50
|
Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor.
|
J Exp Med
|
1995
|
1.88
|
51
|
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients.
|
Transplantation
|
1996
|
1.86
|
52
|
Experience with liver and kidney allografts from non-heart-beating donors.
|
Transplantation
|
1995
|
1.83
|
53
|
Orthotopic liver transplantation in the mouse.
|
Transplantation
|
1991
|
1.82
|
54
|
Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction.
|
J Immunol
|
1997
|
1.81
|
55
|
Pathologic observations in human allograft recipients treated with FK 506.
|
Transplant Proc
|
1990
|
1.80
|
56
|
Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization.
|
Am J Pathol
|
1991
|
1.78
|
57
|
Use of FK 506 in pediatric patients.
|
Transplant Proc
|
1991
|
1.77
|
58
|
Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after renal transplantation: preliminary report.
|
Transplant Proc
|
1993
|
1.72
|
59
|
Transplantation.
|
JAMA
|
1990
|
1.71
|
60
|
Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting.
|
Transplantation
|
1999
|
1.70
|
61
|
Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients.
|
Hum Immunol
|
1985
|
1.65
|
62
|
Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect?
|
Transplantation
|
1988
|
1.61
|
63
|
Weaning of immunosuppression in long-term liver transplant recipients.
|
Transplantation
|
1995
|
1.59
|
64
|
Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation.
|
Transplantation
|
1995
|
1.59
|
65
|
The spectrum of portal vein thrombosis in liver transplantation.
|
Ann Surg
|
1991
|
1.58
|
66
|
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial.
|
Am J Transplant
|
2014
|
1.57
|
67
|
Weaning of immunosuppression in liver transplant recipients.
|
Transplantation
|
1997
|
1.57
|
68
|
Oral glucose tolerance test in liver recipients treated with FK 506.
|
Transplant Proc
|
1990
|
1.56
|
69
|
Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?
|
Am J Surg Pathol
|
2000
|
1.56
|
70
|
Liver transplantation for Wilson's disease: a single-center experience.
|
Liver Transpl Surg
|
1999
|
1.55
|
71
|
Piggyback orthotopic intestinal transplantation.
|
Surg Gynecol Obstet
|
1993
|
1.55
|
72
|
Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both.
|
Transplantation
|
2000
|
1.53
|
73
|
Split tolerance induced by orthotopic liver transplantation in mice.
|
Transplantation
|
1994
|
1.52
|
74
|
A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies.
|
Hepatology
|
1992
|
1.50
|
75
|
Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro.
|
Hepatology
|
1994
|
1.49
|
76
|
FK 506 reverses acute graft-versus-host disease after allogeneic bone marrow transplantation in rats.
|
Surgery
|
1991
|
1.49
|
77
|
An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis.
|
Am J Transplant
|
2001
|
1.48
|
78
|
Pancreas transplantation with enteric drainage under tacrolimus induction therapy.
|
Transplant Proc
|
1997
|
1.48
|
79
|
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients.
|
Transplantation
|
1992
|
1.45
|
80
|
The influence of hepatitis C virus genotypes on the outcome of liver transplantation.
|
Liver Transpl Surg
|
1998
|
1.42
|
81
|
Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption.
|
Am J Pathol
|
1997
|
1.41
|
82
|
Venous-right atrial bypass for superior vena cava thrombosis during orthotopic liver transplantation.
|
Transplantation
|
1997
|
1.39
|
83
|
Organ allocation in the United States: where does it stand? Point.
|
J Am Coll Surg
|
2001
|
1.38
|
84
|
Hepatic resection and transplantation for peripheral cholangiocarcinoma.
|
J Am Coll Surg
|
1997
|
1.36
|
85
|
Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine.
|
J Biol Chem
|
2000
|
1.36
|
86
|
Impact of Orthoclone OKT3 on liver transplantation.
|
Transplant Proc
|
1987
|
1.36
|
87
|
Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation.
|
Hepatology
|
1997
|
1.36
|
88
|
OKT3 in the reversal of acute hepatic allograft rejection.
|
Transplant Proc
|
1987
|
1.35
|
89
|
Neurologic complications of FK 506.
|
Transplant Proc
|
1991
|
1.34
|
90
|
Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system.
|
J Am Coll Surg
|
2000
|
1.33
|
91
|
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression.
|
Ann Surg
|
1994
|
1.33
|
92
|
Assay of FK 506 in plasma.
|
Transplant Proc
|
1990
|
1.32
|
93
|
Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis.
|
Arch Dermatol
|
1992
|
1.32
|
94
|
The development and compensation of biliary cirrhosis in interleukin-6-deficient mice.
|
Am J Pathol
|
2000
|
1.31
|
95
|
Effect of donor age and sex on the outcome of liver transplantation.
|
Hepatology
|
1995
|
1.31
|
96
|
Infections with FK 506 immunosuppression: preliminary results with primary therapy.
|
Transplant Proc
|
1990
|
1.30
|
97
|
Management of splenic artery aneurysms: the significance of portal and essential hypertension.
|
J Am Coll Surg
|
1999
|
1.28
|
98
|
Current status of intestinal transplantation in children.
|
J Pediatr Surg
|
1998
|
1.28
|
99
|
Liver transplantation with cavoportal hemitransposition in the presence of diffuse portal vein thrombosis.
|
Transplantation
|
1998
|
1.28
|
100
|
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data.
|
Transplantation
|
1998
|
1.28
|
101
|
Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C.
|
Am J Transplant
|
2006
|
1.26
|
102
|
Comparison of the small intestine after multivisceral transplantation with the small intestines transplanted with portal or caval drainage.
|
Transplant Proc
|
1992
|
1.26
|
103
|
ORTHOCLONE OKT3 in Treatment of Allografts Rejected Under Cyclosporine-Steroid Therapy.
|
Transplant Proc
|
1986
|
1.25
|
104
|
Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients.
|
Ann Surg
|
1999
|
1.24
|
105
|
Clinical small bowel or small bowel plus liver transplantation under FK 506.
|
Transplant Proc
|
1991
|
1.24
|
106
|
Development and experience with an integrated system for transplantation telepathology.
|
Hum Pathol
|
2001
|
1.23
|
107
|
Effects of in vivo treatment with FK506 on natural killer cells in rats.
|
Transplantation
|
1991
|
1.22
|
108
|
Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis.
|
Surg Gynecol Obstet
|
1993
|
1.21
|
109
|
Donor species complement after liver xenotransplantation. The mechanism of protection from hyperacute rejection.
|
Transplantation
|
1994
|
1.21
|
110
|
Fine-needle aspiration biopsy in pancreatic transplantation.
|
Transplant Proc
|
1995
|
1.21
|
111
|
Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations.
|
Am J Pathol
|
1990
|
1.21
|
112
|
Dynamics of allospecific T lymphocyte infiltration in vascularized human allografts.
|
Immunol Res
|
1986
|
1.20
|
113
|
Liver-derived DEC205+B220+CD19- dendritic cells regulate T cell responses.
|
J Immunol
|
2001
|
1.18
|
114
|
Adverse effects of FK 506 overdosage after liver transplantation.
|
Transplant Proc
|
1993
|
1.18
|
115
|
Tacrolimus in pediatric renal transplantation.
|
Transplantation
|
1996
|
1.18
|
116
|
Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
|
Transplantation
|
1997
|
1.17
|
117
|
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: an interim report.
|
Transplantation
|
1998
|
1.16
|
118
|
Disease gravity and urgency of need as guidelines for liver allocation.
|
Hepatology
|
1994
|
1.16
|
119
|
Liver allograft rejection: an overview of morphologic findings.
|
Am J Surg Pathol
|
1990
|
1.16
|
120
|
Time to detection of cytomegalovirus (CMV) DNA in blood leukocytes is a predictor for the development of CMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation.
|
J Infect Dis
|
1996
|
1.15
|
121
|
Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma.
|
Ann Surg Oncol
|
1995
|
1.15
|
122
|
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients.
|
Transplantation
|
1999
|
1.14
|
123
|
Studies of the hepatotrophic qualities of FK 506 and CyA.
|
Transplant Proc
|
1990
|
1.14
|
124
|
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.
|
Transplant Proc
|
1995
|
1.13
|
125
|
A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation.
|
J Surg Res
|
1996
|
1.13
|
126
|
Clinical intestinal transplantation: focus on complications.
|
Transplant Proc
|
1992
|
1.11
|
127
|
Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides.
|
Mol Ther
|
2000
|
1.10
|
128
|
Improved surgical technique for the establishment of a murine model of aortic transplantation.
|
Microsurgery
|
1998
|
1.10
|
129
|
Dendritic cell replacement in long-surviving liver and cardiac xenografts.
|
Transplantation
|
1993
|
1.10
|
130
|
Tacrolimus in renal transplantation.
|
Transplant Proc
|
1996
|
1.10
|
131
|
Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors.
|
Transplantation
|
1999
|
1.09
|
132
|
Immunopathology of antibodies as effectors of orthotopic liver allograft rejection.
|
Semin Liver Dis
|
1992
|
1.09
|
133
|
Nutritional management of intestinal transplant recipients.
|
Transplant Proc
|
1993
|
1.09
|
134
|
The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis.
|
Transplant Proc
|
1991
|
1.08
|
135
|
Functional cooperation of xenoproteins after hamster-to-rat liver transplantation: With particular reference to hamster C3 and secretory component for rat IgA.
|
Xenotransplantation
|
1995
|
1.08
|
136
|
Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation.
|
Am J Surg Pathol
|
1995
|
1.08
|
137
|
Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up.
|
Transplant Proc
|
1997
|
1.07
|
138
|
Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody.
|
Transplantation
|
1997
|
1.07
|
139
|
Liver transplantation under cyclosporine: a decade of experience.
|
Transplant Proc
|
1991
|
1.07
|
140
|
In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Implications for the establishment and maintenance of donor cell chimerism following liver transplantation.
|
Transplantation
|
1995
|
1.06
|
141
|
Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression.
|
Transplant Proc
|
1991
|
1.06
|
142
|
Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells.
|
Am J Pathol
|
1993
|
1.06
|
143
|
Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model.
|
Am J Pathol
|
1993
|
1.05
|
144
|
Infectivity of hepatic allografts with antibodies to hepatitis B virus.
|
Transplantation
|
1997
|
1.03
|
145
|
Excision and immediate revascularization for hepatic artery pseudoaneurysm following liver transplantation.
|
Transplant Proc
|
1999
|
1.03
|
146
|
Humoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation.
|
Transplant Proc
|
1993
|
1.03
|
147
|
Predicting outcomes after liver transplantation. A connectionist approach.
|
Ann Surg
|
1994
|
1.02
|
148
|
Internal hernia and volvulus of the small bowel following liver transplantation.
|
Transpl Int
|
1997
|
1.02
|
149
|
Lymphoproliferative disorders arising under immunosuppression with FK 506: initial observations in a large transplant population.
|
Transplant Proc
|
1991
|
1.01
|
150
|
A new xenogeneic radiation chimera (hamster-to-rat).
|
Transplantation
|
1994
|
1.01
|
151
|
Microbiologic surveillance as part of human islet transplantation: results of the first 26 patients.
|
Transplant Proc
|
1992
|
1.01
|
152
|
Analysis of T lymphocytes infiltrating human hepatic allografts.
|
Transplant Proc
|
1987
|
1.00
|
153
|
Pediatric renal transplantation under tacrolimus-based immunosuppression.
|
Transplantation
|
1999
|
1.00
|
154
|
Split-liver transplantation: a comparison of ex vivo and in situ techniques.
|
J Pediatr Surg
|
2000
|
1.00
|
155
|
Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts.
|
Transplant Proc
|
1996
|
1.00
|
156
|
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases.
|
Transplantation
|
1998
|
1.00
|
157
|
Upper-abdominal exenteration in transplantation for extensive malignancies of the upper abdomen--an update.
|
Transplantation
|
1991
|
1.00
|
158
|
Weaning of immunosuppression in long-term recipients of living related renal transplants: a preliminary study.
|
Transplant Proc
|
1995
|
0.99
|
159
|
Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia.
|
Liver Transpl Surg
|
1999
|
0.99
|
160
|
FK 506 dosage in human organ transplantation.
|
Transplant Proc
|
1990
|
0.99
|
161
|
The liver transplant waiting list--a single-center analysis.
|
Transplantation
|
1991
|
0.99
|
162
|
Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature.
|
Transplant Proc
|
1997
|
0.98
|
163
|
Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors.
|
Am J Transplant
|
2010
|
0.98
|
164
|
Prospects of clinical xenotransplantation.
|
Transplant Proc
|
1994
|
0.98
|
165
|
Role of UW solution and sodium nitroprusside in reperfusion of liver xenografts from guinea-pig to rat.
|
Xenotransplantation
|
1999
|
0.97
|
166
|
Composition of human islet cell preparations for transplantation.
|
Acta Diabetol
|
1992
|
0.97
|
167
|
Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management.
|
Transplantation
|
1998
|
0.97
|
168
|
Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial.
|
Transplantation
|
1998
|
0.97
|
169
|
Gastrointestinal bleeding after liver transplantation.
|
Transplantation
|
1997
|
0.96
|
170
|
Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes.
|
Hepatology
|
1991
|
0.96
|
171
|
Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients.
|
Ann Surg
|
1996
|
0.96
|
172
|
Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice.
|
Transplantation
|
1996
|
0.96
|
173
|
Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance.
|
J Immunol
|
2001
|
0.96
|
174
|
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
|
Transplantation
|
1999
|
0.96
|
175
|
The politics of grafting cadaver kidneys.
|
Lancet
|
1996
|
0.95
|
176
|
Hepatic artery angioplasty after liver transplantation: experience in 21 allografts.
|
J Vasc Interv Radiol
|
1995
|
0.95
|
177
|
Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging.
|
Transplantation
|
2000
|
0.95
|
178
|
Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21(WAF1/Cip1) as a disease marker and the influence of immunosuppressive drugs.
|
Am J Pathol
|
2001
|
0.95
|
179
|
Tacrolimus rescue therapy for renal allograft rejection--five-year experience.
|
Transplantation
|
1997
|
0.95
|
180
|
Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect.
|
Transplant Proc
|
1991
|
0.95
|
181
|
The 11-year Pittsburgh experience with liver transplantation for hepatocellular carcinoma: 1981-1991.
|
J Surg Oncol Suppl
|
1993
|
0.95
|
182
|
Allogeneic orthotopic liver transplantation in mice: a preliminary study of rejection across well-defined MHC barriers.
|
Transplant Proc
|
1991
|
0.95
|
183
|
An attempt to reverse diabetes by delayed islet cell transplantation in humans.
|
Transplant Proc
|
1997
|
0.94
|
184
|
Non-lymphoid cancer after liver transplantation.
|
Hepatogastroenterology
|
1997
|
0.94
|
185
|
One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events.
|
Transplant Proc
|
1995
|
0.94
|
186
|
Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients.
|
Transplant Proc
|
1991
|
0.94
|
187
|
FK 506 versus cyclosporine in pediatric liver transplantation.
|
Transplant Proc
|
1991
|
0.93
|
188
|
Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA.
|
Transplant Proc
|
1990
|
0.93
|
189
|
Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients.
|
Transplant Proc
|
1991
|
0.93
|
190
|
Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years.
|
Liver Transpl
|
2001
|
0.93
|
191
|
Clinical intestinal transplantation.
|
Transplant Proc
|
1993
|
0.92
|
192
|
Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up.
|
Transplant Proc
|
1997
|
0.92
|
193
|
Evolution of clinical intestinal transplantation: improved outcome and cost effectiveness.
|
Transplant Proc
|
1999
|
0.92
|
194
|
Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation.
|
Transpl Infect Dis
|
2004
|
0.92
|
195
|
Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients.
|
Transplantation
|
1997
|
0.92
|
196
|
Cardiac operations in solid-organ transplant recipients.
|
Ann Thorac Surg
|
1997
|
0.92
|
197
|
Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
|
Transplantation
|
1999
|
0.92
|
198
|
Explanation for loss of the HLA matching effect.
|
Transplant Proc
|
1995
|
0.91
|
199
|
Real-time monitoring of acute liver-allograft rejection using the Banff schema.
|
Transplantation
|
2002
|
0.91
|
200
|
Human islet transplantation: results of the first 37 patients.
|
Transplant Proc
|
1995
|
0.91
|
201
|
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression.
|
Transplant Proc
|
1998
|
0.91
|
202
|
Isolation of the regulatory regions and genomic organization of the porcine alpha1,3-galactosyltransferase gene.
|
Transplantation
|
2000
|
0.91
|
203
|
Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation.
|
Transplantation
|
1994
|
0.91
|
204
|
Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis.
|
Am J Surg Pathol
|
2004
|
0.91
|
205
|
Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506.
|
Transplant Proc
|
1993
|
0.90
|
206
|
Intestinal transplantation in humans under FK 506.
|
Transplant Proc
|
1993
|
0.90
|
207
|
Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation.
|
Liver Transpl
|
2000
|
0.90
|
208
|
Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients.
|
Transplant Proc
|
1996
|
0.90
|
209
|
Isolation and primary cultures of human intrahepatic bile ductular epithelium.
|
In Vitro Cell Dev Biol
|
1988
|
0.90
|
210
|
HLA and cross-reactive antigen group matching for cadaver kidney allocation.
|
Transplantation
|
1997
|
0.89
|
211
|
A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results.
|
J Thorac Cardiovasc Surg
|
2000
|
0.89
|
212
|
FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation.
|
Transplant Proc
|
1991
|
0.89
|
213
|
Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence.
|
Transplantation
|
2001
|
0.89
|
214
|
Lymphocytes of bronchoalveolar lavages from heart-lung transplant recipients.
|
J Heart Transplant
|
1987
|
0.89
|
215
|
Ethical considerations and rationale of adult-to-adult living donor liver transplantation.
|
Liver Transpl
|
2001
|
0.89
|
216
|
Pyruvate inhibits the chronic damage which ensues after ischemia/reperfusion injury of kidneys.
|
Transplant Proc
|
1999
|
0.89
|
217
|
Human islet allotransplantation under FK 506.
|
Transplant Proc
|
1991
|
0.89
|
218
|
Hamster coagulation and serum proteins in rat recipients of hamster xenografts.
|
Transplantation
|
1993
|
0.88
|
219
|
Acute hemodynamic effects of FK 506 during and after orthotopic liver transplantation.
|
Transplant Proc
|
1990
|
0.88
|
220
|
Changes in renal function after liver transplantation under FK 506.
|
Transplant Proc
|
1991
|
0.88
|
221
|
Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
|
Immunology
|
1996
|
0.87
|
222
|
Late-onset renal failure after liver transplantation: role of posttransplant alcohol use.
|
Transplantation
|
2000
|
0.87
|
223
|
Effect of OKT3 on survival and rate of retransplantation.
|
Transplant Proc
|
1987
|
0.87
|
224
|
Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance.
|
Transplantation
|
1997
|
0.87
|
225
|
Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report.
|
Transplant Proc
|
1991
|
0.87
|
226
|
Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.
|
Transplantation
|
2000
|
0.87
|
227
|
Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure.
|
Dig Dis Sci
|
2000
|
0.86
|
228
|
Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus.
|
Liver Transpl Surg
|
1998
|
0.86
|
229
|
Rapid en bloc technique for liver and pancreas procurement.
|
Transplant Proc
|
1997
|
0.86
|
230
|
Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
|
Transplantation
|
1998
|
0.86
|
231
|
Inhibition of IL-12 signaling Stat4/IFN-gamma pathway by rapamycin is associated with impaired dendritic [correction of dendritc] cell function.
|
Transplant Proc
|
2002
|
0.86
|
232
|
HLA antigen expression on cultured human arterial endothelial cells.
|
Tissue Antigens
|
1988
|
0.86
|
233
|
Liver transplantation in patients over sixty years of age.
|
Transplantation
|
1991
|
0.86
|
234
|
Adjuvant bone marrow infusion in clinical organ transplant recipients.
|
Transplant Proc
|
1998
|
0.86
|
235
|
Reversal of acute cellular rejection after renal transplantation with Campath-1H.
|
Transplant Proc
|
2005
|
0.86
|
236
|
Synergistic effect of cold and warm ischemia time on postoperative graft function and outcome in human liver transplantation.
|
Transplant Proc
|
2004
|
0.86
|
237
|
Ex vivo generation of effective Epstein-Barr virus (EBV)-specific CD8+ cytotoxic T lymphocytes from the peripheral blood of immunocompetent Epstein Barr virus-seronegative individuals.
|
Transplantation
|
2000
|
0.86
|
238
|
Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?
|
Dig Dis Sci
|
1998
|
0.86
|
239
|
Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome.
|
Transplantation
|
1997
|
0.86
|
240
|
Urgent revascularization of liver allografts after early hepatic artery thrombosis.
|
Transplantation
|
1996
|
0.86
|
241
|
Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression.
|
Transplant Proc
|
1993
|
0.85
|
242
|
Blockade of tryptophan catabolism prevents spontaneous tolerogenicity of liver allografts.
|
Transplant Proc
|
2001
|
0.85
|
243
|
Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies.
|
Transpl Immunol
|
1994
|
0.85
|
244
|
Application of recipient-derived dendritic cells to induce donor-specific T-cell hyporesponsiveness.
|
Transplant Proc
|
2004
|
0.85
|
245
|
Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
|
Transplantation
|
2001
|
0.85
|
246
|
Outcome of liver transplantation using donors 60 to 79 years of age.
|
Transplant Proc
|
1995
|
0.85
|
247
|
FK 506: a new therapeutic agent for severe recalcitrant psoriasis.
|
Transplant Proc
|
1991
|
0.85
|
248
|
Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients.
|
Pediatr Transplant
|
2001
|
0.85
|
249
|
Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum.
|
Transplant Proc
|
1991
|
0.85
|
250
|
Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants.
|
Nephron
|
1987
|
0.85
|
251
|
Infusion of donor leukocytes to induce tolerance in organ allograft recipients.
|
J Leukoc Biol
|
1999
|
0.85
|
252
|
Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients.
|
Liver Transpl Surg
|
1996
|
0.85
|
253
|
Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome.
|
Transplantation
|
2000
|
0.84
|
254
|
Pediatric liver transplantation in 808 consecutive children: 20-years experience from a single center.
|
Transplant Proc
|
2002
|
0.84
|
255
|
The induction of pseudo-graft-versus-host disease following syngeneic bone marrow transplantation using FK 506.
|
Transplant Proc
|
1991
|
0.84
|
256
|
Survival and quality of life after liver transplantation for acute alcoholic hepatitis.
|
Liver Transpl Surg
|
1997
|
0.84
|
257
|
Interaction between FK 506 and cyclosporine in dogs.
|
Transplant Proc
|
1991
|
0.84
|
258
|
Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus.
|
J Clin Pharmacol
|
2001
|
0.84
|
259
|
HLA histocompatibility and liver transplant survival.
|
Transplant Proc
|
1987
|
0.84
|
260
|
Three years of follow-up of bone marrow-augmented organ transplant recipients: the impact on donor-specific immune modulation.
|
Transplant Proc
|
1997
|
0.84
|
261
|
Spindle cell tumor of the portal vein.
|
J Surg Oncol
|
1995
|
0.84
|
262
|
Liver-derived dendritic cells induce donor-specific hyporesponsiveness: use of sponge implant as a cell transplant model.
|
Cell Transplant
|
2001
|
0.84
|
263
|
Role of splenectomy in human liver transplantation under modern-day immunosuppression.
|
Dig Dis Sci
|
1998
|
0.84
|
264
|
Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation.
|
Transplantation
|
1995
|
0.84
|
265
|
Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies toward further defining their significance.
|
Hepatology
|
1995
|
0.83
|
266
|
Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization.
|
Immunology
|
1995
|
0.83
|
267
|
Interleukin-2 and interleukin-12 mediate distinct effector mechanisms of liver allograft rejection.
|
Liver Transpl Surg
|
1997
|
0.83
|
268
|
Strategy of FK 506 therapy in liver transplant patients: effect of graft function.
|
Transplant Proc
|
1991
|
0.83
|
269
|
Bacterial translocation in clinical intestinal transplantation.
|
Transplant Proc
|
2000
|
0.83
|
270
|
Interferon-gamma induced expression of MHC antigens facilitates identification of donor cells in chimeric transplant recipients.
|
Cell Transplant
|
1994
|
0.83
|
271
|
Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.
|
Transplantation
|
1998
|
0.83
|
272
|
High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation.
|
Transplant Proc
|
1997
|
0.83
|
273
|
Split liver transplantation using Hemiliver graft in the MELD era: a single center experience in the United States.
|
Am J Transplant
|
2014
|
0.83
|
274
|
Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers.
|
Am J Hosp Pharm
|
1992
|
0.83
|
275
|
Relationship between the diagnosis, preoperative evaluation, and prognosis after orthotopic liver transplantation.
|
Ann Surg
|
1988
|
0.83
|
276
|
Influence of donor cardiopulmonary arrest in human liver transplantation: possible role of ischemic preconditioning.
|
Hepatology
|
2000
|
0.83
|
277
|
Concanavalin A simultaneously primes liver hematopoietic and epithelial progenitor cells for parallel expansion during liver regeneration after partial hepatectomy in mice.
|
Hepatology
|
2000
|
0.83
|
278
|
Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression.
|
Transplantation
|
2000
|
0.83
|
279
|
Infectious complications after human small bowel transplantation.
|
Transplant Proc
|
1992
|
0.82
|
280
|
Quality of life after intestinal transplantation and on total parenteral nutrition.
|
Transplant Proc
|
1998
|
0.82
|
281
|
Use of DNA amplification for diagnosis of cytomegalovirus enteritis after intestinal transplantation.
|
Gastroenterology
|
1997
|
0.82
|
282
|
The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival.
|
Transplant Proc
|
2000
|
0.82
|
283
|
Renal transplantation in recipients over the age of 60: the impact of donor age.
|
Transplantation
|
1999
|
0.82
|
284
|
The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us?
|
Transplant Proc
|
1995
|
0.82
|
285
|
Apoptosis of graft-infiltrating cytotoxic T cells: a mechanism underlying "split tolerance" in mouse liver transplantation.
|
Transplant Proc
|
1997
|
0.82
|
286
|
Reducing the length of stay after kidney transplantation--the intensive outpatient unit.
|
Clin Transplant
|
1998
|
0.82
|
287
|
An attempt to induce tolerance with infusion of donor bone marrow in organ allograft recipients.
|
Adv Exp Med Biol
|
1997
|
0.82
|
288
|
Mouse liver transplantation tolerance: the role of hepatocytes and nonparenchymal cells.
|
Transplant Proc
|
1995
|
0.82
|
289
|
Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus.
|
Transplantation
|
2001
|
0.82
|
290
|
Tc-99m hexamethylpropylene amine oxime scintigraphy in the diagnosis of brain death and its implications for the harvesting of organs used for transplantation.
|
Clin Nucl Med
|
2000
|
0.82
|
291
|
Causes of death after liver transplantation in 4000 consecutive patients: 2 to 19 year follow-up.
|
Transplant Proc
|
2001
|
0.82
|
292
|
"Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression.
|
Transplantation
|
1996
|
0.82
|
293
|
Treatment of Cogan's syndrome with FK 506: a case report.
|
Transplant Proc
|
1991
|
0.82
|
294
|
Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events.
|
Liver Transpl Surg
|
1999
|
0.81
|
295
|
Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells.
|
Ther Drug Monit
|
2001
|
0.81
|
296
|
Tacrolimus for rescue of refractory renal allograft rejection.
|
Transplant Proc
|
1998
|
0.81
|
297
|
Histologic monitoring of human small bowel allografts with clinical correlation.
|
Transplant Proc
|
1992
|
0.81
|
298
|
Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity.
|
Transplantation
|
1998
|
0.81
|
299
|
Small bowel transplantation: current progress and clinical application.
|
Hepatogastroenterology
|
1996
|
0.81
|
300
|
Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant.
|
Transplant Proc
|
1991
|
0.81
|
301
|
Sequential infiltration of class I and class II specific alloreactive T cells in human cardiac allografts.
|
Transplant Proc
|
1987
|
0.81
|
302
|
Association of HLA Compatibility and Decreased Liver Transplant Survival.
|
Transplant Proc
|
1988
|
0.81
|
303
|
Human liver xenotransplantation.
|
Xeno
|
1993
|
0.81
|
304
|
Islet cell allotransplantation in diabetic patients. Histologic findings in four adults simultaneously receiving kidney or liver transplants.
|
Am J Pathol
|
1992
|
0.81
|
305
|
Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up.
|
Transplant Proc
|
2001
|
0.81
|
306
|
Hepatic transplantation during pregnancy and the puerperium.
|
J Matern Fetal Med
|
1997
|
0.81
|
307
|
Enteric-drained pancreas transplants monitored by fine-needle aspiration biopsy.
|
Transplant Proc
|
1997
|
0.80
|
308
|
Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient.
|
Cancer
|
1993
|
0.80
|
309
|
Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation.
|
Transplant Proc
|
1995
|
0.80
|
310
|
FK 506 used as rescue therapy for human liver allograft recipients.
|
Transplant Proc
|
1991
|
0.80
|
311
|
Influenza A myocarditis developing in an adult liver transplant recipient despite vaccination: a case report and review of the literature.
|
Transplantation
|
2000
|
0.80
|
312
|
Treatment of isolated pancreatic islets to reverse pancreatectomy-induced and insulin-dependent type I diabetes in humans: a 6-year experience.
|
Transplant Proc
|
1997
|
0.80
|
313
|
An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
|
Transplantation
|
1999
|
0.80
|
314
|
Long-term results of pancreas transplantation under tacrolius immunosuppression.
|
Transplantation
|
1999
|
0.80
|
315
|
Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506).
|
Ann Intern Med
|
1993
|
0.80
|
316
|
Cytokine mRNA profiles in Epstein-Barr virus-associated post-transplant lymphoproliferative disorders.
|
Clin Transplant
|
1999
|
0.80
|
317
|
Effects of donor bone marrow infusion in clinical lung transplantation.
|
Ann Thorac Surg
|
2000
|
0.80
|
318
|
Hyperbaric oxygen therapy for hepatic artery thrombosis after liver transplantation in children.
|
Liver Transpl Surg
|
1999
|
0.80
|
319
|
Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon.
|
Liver Transpl Surg
|
1998
|
0.80
|
320
|
Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients.
|
Transplant Proc
|
1998
|
0.80
|
321
|
Adenovirus-mediated gene transfer to liver grafts: an improved method to maximize infectivity.
|
Transplantation
|
1998
|
0.79
|
322
|
Central venulitis in the allograft liver: a clinicopathologic study.
|
Transplantation
|
1997
|
0.79
|
323
|
The dichotomous functions of passenger leukocytes in solid-organ transplantation.
|
Adv Nephrol Necker Hosp
|
1995
|
0.79
|
324
|
Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function.
|
Transplantation
|
1999
|
0.79
|
325
|
Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
|
Liver Transpl
|
2001
|
0.79
|
326
|
Comparison of the regulatory regions of the alpha1,3galactosyltransferase gene between murine and porcine species.
|
Transplant Proc
|
2001
|
0.79
|
327
|
"Pants" vein jump graft for portal vein and superior mesenteric vein thrombosis in transplantation of the liver.
|
J Am Coll Surg
|
1996
|
0.79
|
328
|
Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era.
|
Transplant Proc
|
1997
|
0.79
|
329
|
Transplantation unresponsiveness induced by liver allografts in mouse strains with various histocompatibility disparities.
|
Transplant Proc
|
1992
|
0.79
|
330
|
Evidence for the presence of multilineage chimerism and progenitors of donor dendritic cells in the peripheral blood of bone marrow-augmented organ transplant recipients.
|
Transplantation
|
1997
|
0.79
|
331
|
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity.
|
Transplantation
|
1998
|
0.79
|
332
|
Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection.
|
Transplantation
|
2001
|
0.79
|
333
|
Transduction of dendritic cells with adenoviral vectors encoding CTLA4-Ig markedly reduces their allostimulatory activity.
|
Transplant Proc
|
1999
|
0.79
|
334
|
Long-term follow-up of tacrolimus rescue therapy for renal allograft rejection.
|
Transplant Proc
|
1997
|
0.79
|
335
|
Liver and kidney transplantation from non-heart beating donors: the Pittsburgh experience.
|
Transplant Proc
|
1995
|
0.79
|
336
|
Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients.
|
Transplantation
|
2001
|
0.79
|
337
|
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.
|
Ann Transplant
|
1997
|
0.79
|
338
|
Two-year experience with FK 506 in pediatric patients.
|
Transplant Proc
|
1993
|
0.78
|
339
|
Changes in quality of life following conversion from CyA to FK 506 in orthotopic liver transplant patients.
|
Transplant Proc
|
1991
|
0.78
|
340
|
A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone and mycophenolate mofetil in primary adult liver transplantation: a single center report.
|
Transplantation
|
2001
|
0.78
|
341
|
Serum protein immunogenicity: implications for liver xenografting.
|
Electrophoresis
|
2000
|
0.78
|
342
|
Prolonged survival of hearts obtained from chimeric donors in a mouse to rat xenotransplant model.
|
Transplant Proc
|
1996
|
0.78
|
343
|
Early recipient-donor switch of the complement type after liver xenotransplantation.
|
Immunol Invest
|
1998
|
0.78
|
344
|
Intestinal transplantation for patients with short gut syndrome and hypercoagulable states.
|
Transplant Proc
|
2000
|
0.78
|
345
|
Propagation of cells expressing donor phenotype (MHC class I, II and Y-chromosome) from the bone marrow of murine liver allograft recipients in response to GM-CSF in vitro.
|
Transplant Proc
|
1995
|
0.78
|
346
|
Clinical and virologic outcomes of hepatitis B and C viral coinfection after liver transplantation: effect of viral hepatitis D.
|
Liver Transpl
|
2000
|
0.78
|
347
|
Concordant hamster-to-rat liver xenotransplantation leads to hyperlipidemia.
|
Transplant Proc
|
2000
|
0.78
|
348
|
Posttransplant lymphoproliferative disorders in small bowel allograft recipients.
|
Transplant Proc
|
2000
|
0.78
|
349
|
Clonal and morphological variation in a posttransplant lymphoproliferative disorder: evolution from clonal T-cell to clonal B-cell predominance.
|
Hum Pathol
|
1998
|
0.78
|
350
|
Primary cultures of human intrahepatic (biliary) epithelial cells.
|
Transplant Proc
|
1988
|
0.78
|
351
|
Contrasting effects of myeloid dendritic cells transduced with an adenoviral vector encoding interleukin-10 on organ allograft and tumour rejection.
|
Immunology
|
2000
|
0.78
|
352
|
Living donor liver transplantation: ethics and safety.
|
Transplant Proc
|
2003
|
0.78
|
353
|
Liver transplantation for acute liver failure: outcome analysis.
|
J Viral Hepat
|
1997
|
0.78
|
354
|
Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome.
|
Blood
|
1999
|
0.78
|
355
|
Patterns of inflammatory vascular endothelial changes in murine liver grafts.
|
Transplantation
|
1995
|
0.78
|
356
|
Low-dose of FK 506 and associated blood levels in allotransplantation of rat liver, heart, and skin.
|
Transplant Proc
|
1992
|
0.78
|
357
|
The two-way paradigm of transplantation immunology.
|
Clin Immunol Immunopathol
|
1996
|
0.78
|
358
|
Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors.
|
Transplant Proc
|
1993
|
0.78
|
359
|
Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus-positive liver and kidney transplantation patients.
|
Transplant Proc
|
2002
|
0.78
|
360
|
Experience with liver and kidney allografts from non-heart-beating donors.
|
Transplant Proc
|
1995
|
0.78
|
361
|
Percutaneous ultrasound-guided pancreas allograft biopsy: a single-center experience.
|
Transplant Proc
|
2005
|
0.78
|
362
|
Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts.
|
Transplant Proc
|
1996
|
0.78
|
363
|
Second-set rejection of mouse liver allografts is dependent on radiation-sensitive nonparenchymal cells of graft bone marrow origin.
|
Transplantation
|
1996
|
0.77
|
364
|
Clinical intestinal transplantation in 1998: Pittsburgh experience.
|
Acta Gastroenterol Belg
|
1999
|
0.77
|
365
|
Pretreatment of recipients (nude rat) with donor antigens leads to prolonged survival of hamster heart xenografts.
|
Transplant Proc
|
1996
|
0.77
|
366
|
Costimulatory molecule-deficient dendritic cell progenitors induce T cell hyporesponsiveness in vitro and prolong the survival of vascularized cardiac allografts.
|
Transplant Proc
|
1997
|
0.77
|
367
|
Marked mitigation of transplant vascular sclerosis in FasLgld (CD95L) mutant recipients. The role of alloantibodies in the development of chronic rejection.
|
Transplantation
|
1999
|
0.77
|
368
|
The University of Pittsburgh: a three and three-quarter-year experience with cadaveric renal transplantation under the point system.
|
Clin Transpl
|
1989
|
0.77
|
369
|
Natural history of Epstein-Barr viral load in peripheral blood of pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disorder.
|
Transplant Proc
|
1999
|
0.77
|
370
|
Evidence for early Th 2 T cell predominance in xenoreactivity.
|
Transplantation
|
1993
|
0.77
|
371
|
Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation.
|
Transplant Proc
|
1998
|
0.77
|
372
|
Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus.
|
Transplantation
|
2001
|
0.77
|
373
|
Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat. A relationship between allo- and autoimmunity.
|
J Clin Invest
|
1996
|
0.77
|
374
|
Adenovirus-mediated gene therapy to liver grafts: successful gene transfer by donor pretreatment.
|
Surgery
|
2000
|
0.77
|
375
|
Documentation in bone-marrow-augmented organ recipients of the presence of dendritic cell progenitors of donor origin.
|
Transplant Proc
|
1997
|
0.77
|
376
|
Transfection with genes encoding CTLA4Ig mediated by adenoassociated virus vectors prolongs survival of heart allografts.
|
Transplant Proc
|
2001
|
0.77
|
377
|
Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients.
|
Transplant Proc
|
1998
|
0.77
|
378
|
Recipient pretreatment with mammalian IL-10 prolongs mouse cardiac allograft survival by inhibition of anti-donor T cell responses.
|
Transplant Proc
|
1999
|
0.77
|
379
|
Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506.
|
Transplant Proc
|
1991
|
0.77
|
380
|
Use of autologous dendritic cells loaded with apoptotic LCL for ex vivo generation of specific CTL from the PBMC of EBV(-) individuals.
|
Transplant Proc
|
2001
|
0.77
|
381
|
Immunosuppressive therapy.
|
Surg Clin North Am
|
1999
|
0.77
|
382
|
Liver graft induced donor specific unresponsiveness without class I and/or class II antigen differences.
|
Transplant Proc
|
1993
|
0.76
|
383
|
Potentiation of the antiproliferative activity of brequinar sodium for murine lymphocytes by exogenous cytidine.
|
Transplant Proc
|
1993
|
0.76
|
384
|
Renal function after conversion from cyclosporine to FK 506 in liver transplant patients.
|
Transplant Proc
|
1991
|
0.76
|
385
|
Kaposi's sarcoma in liver transplant recipients on FK506.
|
Transplantation
|
1998
|
0.76
|
386
|
Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipients.
|
Transplantation
|
1997
|
0.76
|
387
|
Building clinical classifiers using incomplete observations--a neural network ensemble for hepatoma detection in patients with cirrhosis.
|
Methods Inf Med
|
1995
|
0.76
|
388
|
Chimerism after organ transplantation.
|
Curr Opin Nephrol Hypertens
|
1997
|
0.76
|
389
|
Human islet allotransplantation in 18 diabetic patients.
|
Transplant Proc
|
1992
|
0.76
|
390
|
Hemodynamic effects of inhaled nitric oxide in four patients with severe liver disease and pulmonary hypertension.
|
Liver Transpl Surg
|
1997
|
0.76
|
391
|
The effect of splenectomy on cardiac and liver xenografts in the nude rat.
|
Transplant Proc
|
1994
|
0.76
|
392
|
Hepatocytes and liver nonparenchymal cells induce apoptosis in activated T cells.
|
Transplant Proc
|
1999
|
0.76
|
393
|
Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts.
|
Transplant Proc
|
1999
|
0.76
|
394
|
Alcoholic liver disease and transplantation.
|
Transplant Proc
|
2003
|
0.76
|
395
|
Valuation of transmission of porcine endogenous retrovirus into patients subjected to hemoperfusion using an extracorporeal bioartificial liver support system.
|
Transplant Proc
|
2001
|
0.76
|
396
|
Systemic administration of CTLA4-Ig or anti-CD40 ligand antibody inhibits second-set rejection of mouse liver allografts.
|
Transplant Proc
|
1999
|
0.76
|
397
|
Influence of donor condition on postoperative graft survival and function in human liver transplantation.
|
Transplant Proc
|
2000
|
0.76
|
398
|
Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus.
|
Transplant Proc
|
1997
|
0.76
|
399
|
Cytidine potentiates the inhibitory effect of brequinar sodium on xeno-MLR, antibody production, and concordant hamster to rat cardiac xenograft survival.
|
Ann N Y Acad Sci
|
1993
|
0.76
|
400
|
Performance of multi-layer feedforward neural networks to predict liver transplantation outcome.
|
Methods Inf Med
|
1996
|
0.76
|
401
|
Acute pancreatitis after liver transplantation: incidence and contributing factors.
|
Transpl Int
|
1995
|
0.76
|
402
|
Pathology of Chronic Rejection: An Overview of Common Findings and Observations About Pathogenic Mechanisms and Possible Prevention.
|
Graft (Georget Tex)
|
1998
|
0.76
|
403
|
Enhancement of dendritic cell tolerogenicity by genetic modification using adenoviral vectors encoding cDNA for TGF beta 1.
|
Transplant Proc
|
1999
|
0.76
|
404
|
Kidney transplantation with bone marrow augmentation: five-year outcomes.
|
Transplant Proc
|
2001
|
0.76
|
405
|
Almost total absence of chronic rejection in primary pediatric liver transplantation under tacrolimus.
|
Transplant Proc
|
2002
|
0.76
|
406
|
Pretransplant xenogeneic blood transfusion combined with FK 506 prolongs hamster-to-rat liver xenograft survival.
|
Transplant Proc
|
1994
|
0.76
|
407
|
Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival.
|
Transplant Proc
|
1999
|
0.76
|
408
|
Bronchiolitis obliterans organizing pneumonia in a BMT patient receiving FK506.
|
Bone Marrow Transplant
|
1993
|
0.76
|
409
|
Hamster-to-rat liver xenografts protect extrahepatic organs from rejection.
|
Transplant Proc
|
1993
|
0.76
|
410
|
Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
|
Transplantation
|
1999
|
0.76
|
411
|
The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation.
|
Transplant Proc
|
1991
|
0.75
|
412
|
Perioperative treatment with phosphatidic acid inhibitor (Lisofylline leads to prolonged survival of hearts in the guinea pig to rat xenotransplant model.
|
Transplant Proc
|
1996
|
0.75
|
413
|
Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial.
|
Autoimmunity
|
1994
|
0.75
|
414
|
Effect of tacrolimus and splenectomy on engraftment and GVHD after bone marrow xenotransplantation in the reciprocal hamster to rat animal models.
|
Transplant Proc
|
1996
|
0.75
|
415
|
Endothelin-1 receptor blockade and its effect on chronic rejection.
|
Transplant Proc
|
1999
|
0.75
|
416
|
Metabolic changes in the recipient after successful liver xenotransplantation in the rat.
|
Transplant Proc
|
1994
|
0.75
|
417
|
Long-term survival of heart and liver xenografts with splenectomy and FK 506.
|
Transplant Proc
|
1993
|
0.75
|
418
|
Experimental animal model of graft-versus-host disease (GVHD) after small-bowel transplantation: characteristics of the model and application to developing treatment strategies.
|
Transplant Proc
|
1997
|
0.75
|
419
|
Five-year experience with tacrolimus rescue for renal allograft rejection.
|
Transplant Proc
|
1997
|
0.75
|
420
|
Prolonged survival of islet allografts following combined therapy with tacrolimus and leflunomide.
|
Transplant Proc
|
1999
|
0.75
|
421
|
Xenogeneic humoral graft-Vs-host disease following hamster-to-Rat bone marrow transplantation.
|
Transplant Proc
|
2000
|
0.75
|
422
|
Translocation of bacteria from the gastrointestinal tract: protection afforded by lisofylline.
|
Transplant Proc
|
1999
|
0.75
|
423
|
A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients.
|
Transplant Proc
|
2002
|
0.75
|
424
|
Liver transplantation for alcoholic liver disease, viral hepatitis, and hepatic neoplasms.
|
Transplant Proc
|
1991
|
0.75
|
425
|
The bidirectional paradigm of transplant immunology.
|
Ann N Y Acad Sci
|
1995
|
0.75
|
426
|
Metabolic effects of FK 506 in patients with severe psoriasis: short-term follow-up of seven cases.
|
Transplant Proc
|
1991
|
0.75
|
427
|
Alopecia as a consequence of tacrolimus therapy.
|
Transplantation
|
1998
|
0.75
|
428
|
Posttransplant hypertension in blacks versus nonblacks.
|
Transplant Proc
|
1993
|
0.75
|
429
|
Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression.
|
Transplant Proc
|
2001
|
0.75
|
430
|
Outcome of human islet isolation and allotransplantation in 20 consecutive cases.
|
Diabetes Nutr Metab
|
1992
|
0.75
|
431
|
Detection of intrahepatic human islets following combined liver-islet allotransplantation.
|
Pancreas
|
1992
|
0.75
|
432
|
Between Scylla and Charybdis.
|
Ann Surg
|
1995
|
0.75
|
433
|
Donor bone marrow infusion in liver recipients: effect on the occurrence of acute cellular rejection.
|
Transplant Proc
|
2001
|
0.75
|
434
|
Serum cholesterol levels in African Americans after renal transplantation under FK 506 immunosuppression.
|
Transplant Proc
|
1993
|
0.75
|
435
|
Tacrolimus pretreatment attenuates preexisting xenospecific immunity and abrogates hyperacute rejection in a presensitized hamster to rat liver transplant model.
|
Transplantation
|
1996
|
0.75
|
436
|
The role of antibodies in liver graft-induced tolerance in mice: passive transfer of serum and effect of recipient B-cell depletion.
|
Transplant Proc
|
1995
|
0.75
|
437
|
Resource use in liver transplantation.
|
JAMA
|
1999
|
0.75
|
438
|
Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.
|
J Heart Lung Transplant
|
1997
|
0.75
|
439
|
Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet.
|
Am J Kidney Dis
|
1998
|
0.75
|
440
|
Chimerism and xenotransplantation. New concepts.
|
Surg Clin North Am
|
1999
|
0.75
|
441
|
Prevention of sensitization and hyperacute rejection in liver and heart xenografts by FK 506 plus donor antigens.
|
Transplant Proc
|
1995
|
0.75
|
442
|
The long-term efficacy of multivisceral transplantation.
|
Transplant Proc
|
2000
|
0.75
|
443
|
Evidence for engraftment of human bone marrow cells in non-lethally irradiated baboons.
|
Transplantation
|
1997
|
0.75
|
444
|
Nutritional management of intestinal allograft recipients.
|
Transplant Proc
|
1998
|
0.75
|
445
|
Perioperative donor bone marrow infusion in recipients of organ allografts.
|
Transplant Proc
|
1997
|
0.75
|
446
|
Cytokine profile in graft-versus-host disease after small bowel transplantation.
|
Transplant Proc
|
1996
|
0.75
|
447
|
Mechanisms underlying the development of T-cell tolerance following interruption of signalling at the CD28/B7 and CD40/gp39 interface.
|
Transplant Proc
|
1999
|
0.75
|
448
|
Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions.
|
Transplant Proc
|
1999
|
0.75
|
449
|
Posttransplant diabetes in pediatric recipients on tacrolimus.
|
Transplantation
|
1999
|
0.75
|
450
|
Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report.
|
Transplant Proc
|
1996
|
0.75
|
451
|
Xenotransplantation of hamster liver into Gunn rats reserves congenital hyperbilirubinemia.
|
Transplant Proc
|
1996
|
0.75
|
452
|
CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression.
|
Transplant Proc
|
1991
|
0.75
|
453
|
Donor-specific transfusion in the nude rat prolongs survival of subsequently transplanted hamster cardiac xenografts.
|
Transplant Proc
|
1997
|
0.75
|
454
|
Pathologic analysis of recurrent posttransplant lymphoproliferative disorders.
|
Transplant Proc
|
1995
|
0.75
|
455
|
Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations.
|
Transplant Proc
|
2001
|
0.75
|
456
|
Effect of FK 506 on FK-binding protein and transforming growth factor beta gene expression.
|
Transplant Proc
|
1991
|
0.75
|
457
|
Use of MHC class I or II "knock out" mice to delineate the role of these molecules in acceptance/rejection of xenografts.
|
Transplant Proc
|
1996
|
0.75
|
458
|
The antigenicity of serum proteins and their role in xenograft rejection.
|
Transplant Proc
|
1996
|
0.75
|
459
|
Effect of recipient race on waiting time for renal transplantation at the University of Pittsburgh.
|
Transplant Proc
|
1993
|
0.75
|
460
|
Varicella-zoster virus hepatitis and a suggested management plan for prevention of VZV infection in adult liver transplant recipients.
|
Transplantation
|
1995
|
0.75
|
461
|
Outcome of kidney transplantation in African-Americans using tacrolimus.
|
Transplant Proc
|
1997
|
0.75
|
462
|
Effect of FK 506 on human pancreatic islets following renal subcapsular transplantation in diabetic nude mice.
|
Transplant Proc
|
1992
|
0.75
|
463
|
Combined blockade of CD28/B7 and CD40/CD40L costimulatory pathways prevents the onset of chronic rejection.
|
Transplant Proc
|
1998
|
0.75
|
464
|
Allospecificity of liver allograft-derived lymphocytes and correlation with clinicopathologic findings.
|
Transplant Proc
|
1988
|
0.75
|
465
|
Cytidine potentiates the inhibitory effect of brequinar sodium on concordant cardiac xenograft rejection.
|
Transplant Proc
|
1994
|
0.75
|
466
|
Tacrolimus rescue therapy for renal transplant rejection.
|
Transplant Proc
|
1996
|
0.75
|
467
|
Managing hepatic bleeding with autologous plasma/collagen-based fibrin sealant.
|
Arch Surg
|
2001
|
0.75
|
468
|
Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation.
|
Clin Pharmacol Ther
|
1998
|
0.75
|
469
|
Cross-tolerance of recipient-derived transforming growth factor-beta dendritic cells.
|
Transplant Proc
|
2007
|
0.75
|
470
|
A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report.
|
J Urol
|
1998
|
0.75
|
471
|
Induction of donor-specific transplantation tolerance to skin and cardiac allografts using mixed chimerism in (A + B-->A) in rats.
|
Cell Transplant
|
1994
|
0.75
|
472
|
The pharmacodynamics of pentobarbital following FK 506 therapy.
|
Transplant Proc
|
1991
|
0.75
|
473
|
Cytokine messenger RNA profiles in hamster-to-rat liver xenografts.
|
Transplant Proc
|
1993
|
0.75
|
474
|
Loss of serum bicarbonate after discordant liver xenotransplantation.
|
Transplant Proc
|
2000
|
0.75
|
475
|
Complement and target cells belong to the same species after liver xenografting: protection from hyperacute rejection.
|
Transplant Proc
|
1994
|
0.75
|
476
|
The immunolymphatic theory of chronic rejection.
|
Transplant Proc
|
1997
|
0.75
|
477
|
Ischemia/reperfusion injury induces chronic changes in the small bowel.
|
Transplant Proc
|
2000
|
0.75
|
478
|
Survival of human hepatocellular aggregates in athymic mice.
|
Transplant Proc
|
1992
|
0.75
|
479
|
The role of Fas/FasL apoptotic pathway in the development of chronic rejection.
|
Transplant Proc
|
1999
|
0.75
|
480
|
Intrahepatic human islet transplantation at the University of Pittsburgh: results in 25 consecutive cases.
|
Transplant Proc
|
1992
|
0.75
|
481
|
Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients.
|
Transplant Proc
|
1997
|
0.75
|
482
|
Occult nonhematopoietic malignancies present at autopsy in solid organ transplant patients who died within 100 days.
|
Transplantation
|
2001
|
0.75
|
483
|
Preservation injury and acute rejection of rat intestinal grafts: protection afforded by pyruvate.
|
J Gastrointest Surg
|
2000
|
0.75
|
484
|
Orthotopic liver transplantation in U.S. veterans under primary tacrolimus immunosupression.
|
Surg Technol Int
|
1996
|
0.75
|
485
|
Should reimbursement be denied for liver transplantation in patients with hepatocellular carcinoma?
|
JAMA
|
1997
|
0.75
|
486
|
Human islet allograft follow-up: long-term islet function and over 3 years of insulin independence.
|
Transplant Proc
|
1994
|
0.75
|
487
|
Xenoreactivity in mouse + rat-->mouse chimeras.
|
Transplant Proc
|
1993
|
0.75
|
488
|
FcgammaRllc 13Q/STP polymorphism influences the antibody-dependent cytotoxicity levels triggered by natural killer cells against pig aortic endothelial cells.
|
Transplant Proc
|
2001
|
0.75
|
489
|
Neutralization of IL-12 reverses rejection of mouse liver allografts from Flt3-ligand-treated donors and is associated with suppression of both cellular and humoral responses.
|
Transplant Proc
|
2001
|
0.75
|
490
|
Treatment with CTLA4-Ig inhibits rejection of liver allografts from FIt3-ligand-treated donors.
|
Transplant Proc
|
1999
|
0.75
|
491
|
Reconstruction of an abnormal hepatic vein in a donor liver: a case report.
|
Transplantation
|
1998
|
0.75
|
492
|
FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts.
|
Transplant Proc
|
1994
|
0.75
|
493
|
Suppression of alloreactive T-cell activation by murine liver F4/80+ accessory cells and kinetics of intrahepatic F4/80+ cells following liver transplantation.
|
Transplant Proc
|
1995
|
0.75
|
494
|
Hepatitis C virus and renal failure.
|
Transplant Proc
|
2003
|
0.75
|
495
|
A simplified method for growing dendritic cells from rat bone marrow.
|
Adv Exp Med Biol
|
1995
|
0.75
|
496
|
Outcome of kidney transplantation under tacrolimus-based immunosuppression in elderly patients.
|
J Transpl Coord
|
1999
|
0.75
|
497
|
Maturation of B-cell clones.
|
Prog Clin Biol Res
|
1980
|
0.75
|
498
|
Evidence of microchimerism after pretransplant blood transfusion and FK 506 in liver xenograft.
|
Transplant Proc
|
2000
|
0.75
|
499
|
Early clinical and histologic viability of human liver-small intestinal allografts after implantation.
|
Clin Transplant
|
1994
|
0.75
|
500
|
Effect of t-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil.
|
Liver Transpl Surg
|
1999
|
0.75
|
501
|
FK 506 interaction with danazol.
|
Lancet
|
1993
|
0.75
|
502
|
Mechanisms of protection from humoral rejection by a xenografted liver.
|
Transplant Proc
|
1995
|
0.75
|
503
|
Administration of CTLA4-Ig enhances the incidence of hamster-to-rat xenogeneic bone marrow engraftment and alters the presentation of graft-vs-host disease.
|
Transplant Proc
|
2000
|
0.75
|
504
|
Role of MHC class I and CD8(+) T cells in the pathogenesis of chronic rejection.
|
Transplant Proc
|
2001
|
0.75
|
505
|
Immunological factors influencing liver graft survival.
|
Gastroenterol Clin North Am
|
1988
|
0.75
|
506
|
Administration of antisense oligodeoxyribonucleotides against mRNA of CD80 or CD86 prolongs survival of cardiac allografts by inhibition of CTL activity.
|
Transplant Proc
|
2001
|
0.75
|
507
|
A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up.
|
Transplant Proc
|
1999
|
0.75
|
508
|
Hamster-to-rat bone marrow xenotransplantation and humoral graft vs. host disease.
|
Xenotransplantation
|
2001
|
0.75
|
509
|
[Experience of orthotopic liver transplantation from non-heart-beating donors at the University of Pittsburgh Medical Center].
|
Nihon Geka Gakkai Zasshi
|
1999
|
0.75
|
510
|
Blockade of the CD28/B7 and CD40/CD40L costimulatory pathways does not ameliorate chronic rejection in a mouse aortic allograft model of direct antigen presentation.
|
Transplant Proc
|
2001
|
0.75
|
511
|
Quantitative assessment of the development of hepatoma in a buffalo rat model.
|
Transplant Proc
|
1997
|
0.75
|
512
|
Cadaveric liver donors; what are the limits?
|
Transplant Proc
|
1996
|
0.75
|
513
|
The patient with chronic hepatitis C.
|
Liver Transpl Surg
|
1996
|
0.75
|
514
|
Advances in hepatitis B virus infection.
|
Transplant Proc
|
2003
|
0.75
|
515
|
I-131 orthoiodohippurate assessment of renal function after heart transplantation.
|
Clin Nucl Med
|
1999
|
0.75
|
516
|
Long-term nutritional monitoring after clinical intestinal transplantation.
|
Transplant Proc
|
1998
|
0.75
|
517
|
Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression.
|
Transplant Proc
|
2000
|
0.75
|
518
|
The protection from humoral rejection given by a liver xenograft is species-specific and non-MHC restricted.
|
Transplant Proc
|
1995
|
0.75
|
519
|
Immune complex disease in immunosuppressed rat recipients of hamster liver xenografts.
|
Transplant Proc
|
2001
|
0.75
|
520
|
Phenotype and allostimulatory function of dendritic cells treated with antisense oligodeoxyribonucleotides targeting CD80 or CD86 mRNA.
|
Transplant Proc
|
2001
|
0.75
|
521
|
The effect of thymus transplantation on allograft rejection in thymectomized bone marrow chimeras.
|
Transplant Proc
|
1990
|
0.75
|
522
|
The role of liver stromal cells in dendritic cells development in mice.
|
Transplant Proc
|
2010
|
0.75
|
523
|
The latest advances in liver transplantation at the pittsburgh transplantation institute: evolution of FK506, liver-intestinal transplantation, clinical xenotransplantation, and the induction of graft acceptance.
|
Surg Technol Int
|
1994
|
0.75
|
524
|
Short exposure to hepatocyte growth factor stimulates adult human pancreatic beta-cell proliferation.
|
Transplant Proc
|
1995
|
0.75
|
525
|
Hepatocytes or liver nonparenchymal cells plus FK 506 prolong liver xenograft survival.
|
Transplant Proc
|
1994
|
0.75
|
526
|
Presentation of MHC-disparate donor antigens predominantly by the indirect pathway results in the development of posttransplant vasculopathy: salutary effects of perioperative costimulatory blockade.
|
Transplant Proc
|
2001
|
0.75
|
527
|
Bronchoalveolar macrophage-lymphocyte reactivity in heart-lung transplant recipients.
|
Transplant Proc
|
1987
|
0.75
|
528
|
[Clinical experience with FK 506].
|
Presse Med
|
1991
|
0.75
|
529
|
Functional studies of in vivo committed lymphocytes propagated from organ transplants.
|
Prog Clin Biol Res
|
1986
|
0.75
|
530
|
Modified temporary end-to-side portocaval shunt in liver and small bowel transplantation.
|
Pediatr Transplant
|
2001
|
0.75
|
531
|
Simultaneous pancreas-kidney transplantation at the University of Pittsburgh.
|
Clin Transpl
|
1999
|
0.75
|
532
|
Combined veno-venous bypass and high volume hemofiltration during orthotopic liver transplantation.
|
ASAIO J
|
1994
|
0.75
|
533
|
The combined use of sublethal irradiation and costimulatory blockade to generate mixed bone marrow chimeras.
|
Transplant Proc
|
1999
|
0.75
|